Search results
Wall Street Analysts Think Cytokinetics (CYTK) Could Surge 30.54%: Read This Before Placing a Bet
Cytokinetics (CYTK) closed the last trading session at $81.93, gaining 8.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 32.76% Upside in Broadcom Inc. (AVGO): Can the Stock Really Move This High?
Broadcom Inc. (AVGO) closed the last trading session at $389.11, gaining 3.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data
Shares of Biogen BIIB were down 8.2% yesterday after the company presented data from the phase II CELIA study evaluating its experimental tau-targeting Alzheimer’s disease (AD) drug, diranersen, at
Roblox Targets a Q3 DAU Recovery: What Could Drive the Rebound?
Roblox Corporation RBLX expects daily active users to return to sequential growth in the third quarter of 2026, supported by seasonal trends and planned product changes intended to address near-term
OnKure Therapeutics Spotlights Allosteric PI3Kα Drugs as 2027 IND Targets Near
Key Points
- Interested in OnKure Therapeutics, Inc.? Here are five stocks we like better.
- OnKure Therapeutics is advancing two lead allosteric PI3Kα inhibitors, OKI-355 for vascular anomalies
PTC Targets ALM Growth as Codebeamer Gains Traction in Software-Defined Products
Key Points
- Interested in PTC Inc.? Here are five stocks we like better.
- PTC says its Codebeamer ALM platform is gaining traction as software-defined products, regulatory pressure, and
Should Value Investors Buy Target (TGT) Stock?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Wall Street Analysts Predict a 27.98% Upside in Cushman & Wakefield (CWK): Here's What You Should Know
Cushman & Wakefield (CWK) closed the last trading session at $13.83, gaining 7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Should You Buy the Dip in Drone Stocks and ETFs?
Drones have revolutionized warfare in the Middle East and Ukraine. Drone attacks are among Iran's core tactics for striking US bases and targets in Gulf states.
The US military has deployed sea
Brookfield Shareholders Back New BN Deal as Firm Targets 20% Earnings Growth
Key Points
- Interested in Brookfield Corporation? Here are five stocks we like better.
- Brookfield shareholders approved a major transaction to combine Brookfield Corporation and Brookfield
3 Picks-and-Shovels Stocks Powering the Humanoid Robotics Buildout
Key Points
- Interested in Ambarella, Inc.? Here are five stocks we like better.
- Rather than picking a winning robot maker, investors can target suppliers like chipmakers and sensor firms that
J.B. Hunt Stock Could Reach $340 as Trucking Capacity Shrinks
Key Points
- Interested in J.B. Hunt Transport Services, Inc.? Here are five stocks we like better.
- J.B. Hunt shares are rising toward a potential $340 target as industry-wide trucking capacity
IPG Photonics Targets Medical Laser Growth With €300M Lumibird Medical Deal
Key Points
- Interested in IPG Photonics Corporation? Here are five stocks we like better.
- IPG Photonics has signed a binding offer to acquire Lumibird Medical for €300 million, plus a potential
MRNA Advances Cancer Pipeline With New Immunotherapy Study
Moderna MRNA announced that it has dosed the first U.S. patient in a phase I study evaluating mRNA-4200, an investigational off-the-shelf, tumor-targeted cancer antigen therapy.
The study will
QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway
uniQure N.V. QURE remains a catalyst-driven gene therapy stock, with AMT-130 shaping most of the investment debate. The program targets Huntington’s disease, an area where disease-modifying options
Shopify's Quiet AI Strategy Could Be Its Biggest Advantage Yet
Key Points
- Interested in Shopify Inc.? Here are five stocks we like better.
- Jefferies upgraded Shopify to Buy with a $160 price target this week, citing its potential as the infrastructure layer
Wall Street Analysts Predict a 25.8% Upside in CBRE (CBRE): Here's What You Should Know
CBRE Group (CBRE) closed the last trading session at $140.96, gaining 7.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Believe Methanex (MEOH) Could Rally 28.32%: Here's is How to Trade
Methanex (MEOH) closed the last trading session at $54.81, gaining 3.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
How Does Citigroup Plan to Achieve Its Medium-Term ROTCE Target?
Citigroup Inc.'s C second-quarter 2026 results underscore the progress of its multi-year transformation, with stronger profitability signaling that the strategy is beginning to pay off. With this
Why Costco's Warehouse Growth Story Is Far From Over
Costco Wholesale Corporation COST continues to expand its physical footprint at a sustained pace of warehouse openings. The company is targeting more than 30 net-new locations annually, supported by